Brief: Celldex Announces Pricing Of $300 Million Public Offering Of Common Stock
April 1 (Reuters) - Celldex Therapeutics Inc CLDX.O: CELLDEX ANNOUNCES PRICING OF $300 MILLION PUBLIC OFFERING OF COMMON STOCK CELLDEX THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 10,345,000 SHARES AT $29.00 PER SHARE Source text: ID:nGNXrTXym Further company coverage: CLDX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials